Philip Oyer

Publication Details

  • Chronic ovine evaluation of a totally implantable electrical left ventricular assist system. ASAIO transactions / American Society for Artificial Internal Organs Ramasamy, N., Chen, H., Miller, P. J., Jassawalla, J. S., Greene, B. A., Ocampo, A., Siegel, L. C., Oyer, P. E., Portner, P. M. 1989; 35 (3): 402-404

    Abstract:

    The totally implantable Novacor left ventricular assist system (LVAS) comprises a pump/drive unit (VAD), electronic control and power subsystem (ECP), variable volume compensator (VVC), and belt skin transformer (BST). The system is now undergoing chronic in vivo evaluation. Cumulative animal testing of VAD, VVC, and BST subsystems are 12.1, 4.9, and 43 years, respectively. The longest implants were 279 days for the VAD, 767 days for the VVC, and 1,148 days for the BST. A chronic implant of the total system was electively terminated at 260 days. The LVAS was powered via the BST. Continuously monitored hemodynamic and pump parameters have demonstrated normal hemodynamics and LVAS operation. Periodic VVC determinations suggest a 0.8 ml/day diffusive gas loss. Tether-free operation has been demonstrated with an Ag-Zn battery backpack. The animal was healthy and free of infection as indicated by routine hematologic, biochemical and serum enzyme determinations. Hemolysis is minimal (plasma free hemoglobin less than 5 mg%). Pump output ranged from 7 to 8 L/min. Severe valve calcification was the reason for elective termination at 260 days. This preclinical in vivo experience, and in vitro reliability studies, demonstrate efficacy of the total system.

    View details for PubMedID 2597489

Stanford Medicine Resources:

Footer Links: